The National Accounts Director, US Biosimilars will lead Lupin's strategic relationships with assigned national and specialty Group Purchasing Organizations (GPOs), national distributors, and large provider groups to support access, launch readiness, and sustainable portfolio growth. This role will own national account strategy, senior customer engagement, commercial agreement development and negotiation within approved parameters, and implementation and performance.
KEY RESPONSIBILITIES
• Develop and execute strategic plans for assigned GPOs, national distributors, and large provider groups, including stakeholder maps, opportunities, engagement, and performance objectives.
• Build relationships with customer executives and contracting, purchasing, distribution, membership, finance, and analytics stakeholders; represent Lupin in negotiations and business reviews.
• Lead commercial discussions and negotiations within approved pricing, financial, legal, and compliance parameters.
• Evaluate agreements based on access, customer value, provider economics, distribution requirements, net sales, margin, implementation needs, and portfolio value.
• Coordinate contract activation, eligibility, communications, distribution dependencies, product availability, and implementation with appropriate internal and customer teams.
• Monitor account and agreement performance; address access, adoption, distribution, or execution barriers and develop renewal and growth strategies.
• Incorporate provider purchasing, reimbursement, payer mix, buy-and-bill, Medicare Part B, ASP, inventory, distribution economics, and cash-flow considerations into account strategy.
• Support prelaunch planning and account readiness for pipeline products, including customer intelligence, priorities, timelines, distribution needs, and activation plans.
• Provide national account intelligence, competitive insights, and recommendations to US Biosimilars leadership.